| 000 | 01227 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513022339.0 | ||
| 264 | 0 | _c19800627 | |
| 008 | 198006s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/0024-3205(80)90317-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeller, E | |
| 245 | 0 | 0 |
_aDifferential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels. _h[electronic resource] |
| 260 |
_bLife sciences _cFeb 1980 |
||
| 300 |
_a541-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHaloperidol _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhenylacetates _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 700 | 1 | _aFriedhoff, A J | |
| 700 | 1 | _aFriedman, E | |
| 773 | 0 |
_tLife sciences _gvol. 26 _gno. 7 _gp. 541-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0024-3205(80)90317-3 _zAvailable from publisher's website |
| 999 |
_c7365845 _d7365845 |
||